Skip to content

Esketamine versus Etomidate for Rapid-Sequence Intubation in Adult Critically Ill Patients: A Prospective Observational Study

Esketamine versus Etomidate for Rapid-Sequence Intubation in Adult Critically Ill Patients: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104010
Enrollment
Unknown
Registered
2025-06-10
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Signed written informed consent; 3.Patients requiring rapid oral induction of tracheal intubation;

Exclusion criteria

Exclusion criteria: 1.Patients unsuitable for rapid sequence induction intubation; 2.Patients with known hypersensitivity to etomidate and esketamine; 3.Patients with cardiogenic shock; 4.Patients with known hypersensitivity to etomidate and ketamine; 5.Hypertension (SBP >=140 mmHg) before intubation; 6.Heart rate >=140 beats/minute before intubation; 7.Clinicians believe that induction medications other than ketamine or etomidate are needed to provide optimal treatment for the patient; 8.Informed consent cannot be obtained from the patient or guardian; 9.Previously enrolled patients;

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure, MAP;

Secondary

MeasureTime frame
Changes of other hemodynamic indexes during the peri-intubation period;Intubation-related adverse events;Mortality;7-Day mortality;

Countries

China

Contacts

Public ContactZhang Sheng

Peking University Shenzhen Hospital

zs80icu@163.com+86 755 83923333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026